Overview

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

Status:
Terminated

Trial end date:
2012-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether BMS-823778 is safe and effective in the treatment of hypertension in overweight and obese patients.

Phase:

Phase 2

Details

Lead Sponsor:

Bristol-Myers Squibb